Arcus Historical Income Statement

RCUS Stock

USD 17.40 0.02 0.11%

Historical analysis of Arcus Biosciences income statement accounts such as Selling General Administrative of 122.8 M, Total Revenue of 98.2 M, Other Operating Expenses of 479.9 M or Research Development of 357 M can show how well Arcus Biosciences performed in making a profits. Evaluating Arcus Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Arcus Biosciences's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Arcus Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Arcus Biosciences is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Arcus Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more information on how to buy Arcus Stock please use our How to Invest in Arcus Biosciences guide.

About Arcus Income Statement Analysis

Arcus Biosciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Arcus Biosciences shareholders. The income statement also shows Arcus investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Arcus Biosciences Income Statement Chart

At this time, Arcus Biosciences' Income Tax Expense is comparatively stable compared to the past year. Tax Provision is likely to gain to about 6.3 M in 2024, whereas Interest Expense is likely to drop slightly above 1.3 M in 2024.

Selling General Administrative Other Operating Expenses Research Development Cost Of Revenue Selling And Marketing Expenses

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Arcus Biosciences. It is also known as Arcus Biosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Arcus Biosciences income statement and represents the costs associated with goods and services Arcus Biosciences provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Arcus Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Arcus Biosciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Arcus Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

For more information on how to buy Arcus Stock please use our How to Invest in Arcus Biosciences guide.At this time, Arcus Biosciences' Income Tax Expense is comparatively stable compared to the past year. Tax Provision is likely to gain to about 6.3 M in 2024, whereas Interest Expense is likely to drop slightly above 1.3 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Income	657K	16M	41M	43.1M
Net Interest Income	397K	14M	39M	41.0M

Interest Income Net Interest Income

Arcus Biosciences income statement Correlations

	Net Interest Income	Interest Income	Depreciation And Amortization	Selling General Administrative	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Reconciled Depreciation	Non Operating Income Net Other	Selling And Marketing Expenses
Net Interest Income		1.0	0.55	0.86	-0.58	0.83	-0.91	-0.89	-0.88	0.82	-0.88	0.91	0.83	-0.89	1.0	-0.9	0.83	-0.68	-0.92
Interest Income	1.0		0.57	0.87	-0.57	0.84	-0.91	-0.9	-0.89	0.83	-0.89	0.91	0.84	-0.89	1.0	-0.9	0.83	-0.69	-0.91
Depreciation And Amortization	0.55	0.57		0.85	0.15	0.85	-0.7	-0.71	-0.71	0.84	-0.7	0.35	0.85	-0.71	0.55	-0.71	0.82	-0.85	-0.3
Selling General Administrative	0.86	0.87	0.85		-0.16	1.0	-0.85	-0.84	-0.83	0.99	-0.82	0.74	1.0	-0.84	0.86	-0.84	0.9	-0.95	-0.72
Gross Profit	-0.58	-0.57	0.15	-0.16		-0.12	0.59	0.58	0.58	-0.11	0.6	-0.69	-0.12	0.58	-0.58	0.58	-0.3	-0.02	0.59
Other Operating Expenses	0.83	0.84	0.85	1.0	-0.12		-0.81	-0.81	-0.79	1.0	-0.78	0.73	1.0	-0.8	0.84	-0.81	0.89	-0.96	-0.7
Operating Income	-0.91	-0.91	-0.7	-0.85	0.59	-0.81		1.0	1.0	-0.8	1.0	-0.82	-0.81	1.0	-0.91	1.0	-0.88	0.7	0.74
Net Income From Continuing Ops	-0.89	-0.9	-0.71	-0.84	0.58	-0.81	1.0		1.0	-0.79	1.0	-0.8	-0.81	1.0	-0.89	1.0	-0.87	0.7	0.72
Ebit	-0.88	-0.89	-0.71	-0.83	0.58	-0.79	1.0	1.0		-0.78	1.0	-0.79	-0.79	1.0	-0.88	1.0	-0.87	0.69	0.7
Research Development	0.82	0.83	0.84	0.99	-0.11	1.0	-0.8	-0.79	-0.78		-0.77	0.73	1.0	-0.79	0.83	-0.79	0.88	-0.97	-0.7
Ebitda	-0.88	-0.89	-0.7	-0.82	0.6	-0.78	1.0	1.0	1.0	-0.77		-0.79	-0.78	1.0	-0.88	1.0	-0.86	0.68	0.71
Cost Of Revenue	0.91	0.91	0.35	0.74	-0.69	0.73	-0.82	-0.8	-0.79	0.73	-0.79		0.73	-0.8	0.91	-0.8	0.73	-0.63	-0.9
Total Operating Expenses	0.83	0.84	0.85	1.0	-0.12	1.0	-0.81	-0.81	-0.79	1.0	-0.78	0.73		-0.8	0.84	-0.81	0.89	-0.96	-0.7
Income Before Tax	-0.89	-0.89	-0.71	-0.84	0.58	-0.8	1.0	1.0	1.0	-0.79	1.0	-0.8	-0.8		-0.89	1.0	-0.87	0.7	0.71
Total Other Income Expense Net	1.0	1.0	0.55	0.86	-0.58	0.84	-0.91	-0.89	-0.88	0.83	-0.88	0.91	0.84	-0.89		-0.9	0.82	-0.69	-0.92
Net Income	-0.9	-0.9	-0.71	-0.84	0.58	-0.81	1.0	1.0	1.0	-0.79	1.0	-0.8	-0.81	1.0	-0.9		-0.87	0.7	0.73
Reconciled Depreciation	0.83	0.83	0.82	0.9	-0.3	0.89	-0.88	-0.87	-0.87	0.88	-0.86	0.73	0.89	-0.87	0.82	-0.87		-0.83	-0.56
Non Operating Income Net Other	-0.68	-0.69	-0.85	-0.95	-0.02	-0.96	0.7	0.7	0.69	-0.97	0.68	-0.63	-0.96	0.7	-0.69	0.7	-0.83		0.55
Selling And Marketing Expenses	-0.92	-0.91	-0.3	-0.72	0.59	-0.7	0.74	0.72	0.7	-0.7	0.71	-0.9	-0.7	0.71	-0.92	0.73	-0.56	0.55

Click cells to compare fundamentals

Arcus Biosciences Account Relationship Matchups

Arcus Biosciences income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Net Interest Income	5.2M	1.4M	397K	14M	39M	41.0M
Interest Income	5.2M	1.4M	657K	16M	41M	43.1M
Depreciation And Amortization	3.6M	4.4M	7.1M	14M	8M	6.1M
Selling General Administrative	25.2M	42.4M	72.3M	104M	117M	122.9M
Total Revenue	15M	77.5M	382.9M	112M	117M	98.2M
Gross Profit	15M	(81.5M)	375.8M	98M	(223M)	(211.9M)
Other Operating Expenses	103.7M	201.8M	328.6M	392M	457M	479.9M
Operating Income	(88.7M)	(124.2M)	54.2M	(280M)	(340M)	(323M)
Net Income From Continuing Ops	(84.7M)	(122.9M)	52.8M	(267M)	(307M)	(291.7M)
Ebit	(88.7M)	(122.9M)	54.9M	(264M)	(291M)	(276.5M)
Research Development	78.5M	159.3M	256.3M	288M	340M	357M
Ebitda	(85.1M)	(118.5M)	62.0M	(250M)	(283M)	(268.9M)
Cost Of Revenue	78.5M	159M	7.1M	14M	340M	357M
Total Operating Expenses	103.7M	201.8M	328.6M	392M	457M	479.9M
Income Before Tax	(84.7M)	(122.9M)	54.6M	(266M)	(301M)	(286.0M)
Total Other Income Expense Net	4.0M	1.4M	397K	14M	39M	41.0M
Net Income Applicable To Common Shares	(84.7M)	(122.9M)	52.8M	(267M)	(240.3M)	(228.3M)
Net Income	(75.9M)	(116.7M)	53M	(267M)	(307M)	(291.7M)
Income Tax Expense	(8.8M)	(6.2M)	1.8M	1M	6M	6.3M
Reconciled Depreciation	3.6M	4.2M	3.8M	6M	8M	5.0M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Arcus Stock Analysis

When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Arcus Historical Income Statement

About Arcus Income Statement Analysis

Arcus Biosciences Income Statement Chart

Other Operating Expenses

Cost Of Revenue

Arcus Biosciences income statement Correlations

Arcus Biosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Arcus Biosciences income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Arcus Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Interest Income	+ 1.0	Net Interest Income
Total Other Income Expense Net	+ 1.0	Net Interest Income
Total Other Income Expense Net	+ 1.0	Interest Income
Other Operating Expenses	+ 1.0	Selling General Administrative
Total Operating Expenses	+ 1.0	Selling General Administrative
Research Development	+ 1.0	Other Operating Expenses

Non Operating Income Net Other	- 0.97	Research Development
Non Operating Income Net Other	- 0.96	Total Operating Expenses
Non Operating Income Net Other	- 0.96	Other Operating Expenses
Non Operating Income Net Other	- 0.95	Selling General Administrative
Selling And Marketing Expenses	- 0.92	Total Other Income Expense Net
Selling And Marketing Expenses	- 0.92	Net Interest Income